An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home

Vaccine

Volumn 28, Issue 47, 2010, Pages 7536-7541

  Camilloni, B ^a   Neri, M ^a   Lepri, E ^a   Basileo, M ^a   Sigismondi, N ^b   Puzelli, S ^c   Donatelli, I ^c   Iorio, A M ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Nursing Home Bartolomei Castori   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

B Victoria and B Yamagata lineage viruses; Cross reactive antibodies; Influenza vaccine immunogenicity and efficacy; Mismatched epidemic and vaccine antigens

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE;

AGED; ARTICLE; DRUG EFFICACY; EPIDEMIC; FEMALE; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; NURSING HOME; PRIORITY JOURNAL; SEASONAL INFLUENZA; WINTER;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DISEASE OUTBREAKS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ITALY; MIDDLE AGED; NURSING HOMES; PHYLOGENY; POLYSORBATES; SQUALENE;

EID: 77958195467     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.064     Document Type: Article

References (35)

1. Goodman R.A., Orenstein W.A., Munrow F., Smith S.C., Sikes R.K. Impact of influenza A in nursing home. JAMA 1982, 247:1451-1452.
2. Budnick L.D., Stricof R.L., Ellis F. An outbreak of influenza A in a nursing home, 1982 NY State. J Med 1984, 84:235-238.
3. D'Alessio D.J., Cox P.M., Dick E.C. Failure of inactivated influenza vaccine to protect an aged population. JAMA 1969, 210:485-489.
4. Strassburg M.A., Greenland S., Sorvillo F.J., Lieb L.E., Habel L.A. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986, 4:38-44.
5. Arden N., Monto A.S., Ohmit S.E. Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic. Am J Publ Health 1995, 85:399-401.
6. Jefferson T., Rivetti D., Rivetti A., Di Pierantoni C., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366:1165-1174.
7. Carrat F., Flahault A. Influenza vaccines: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
8. WHO Weekly recommended composition of influenza virus vaccine for use in the 2008-2009 influenza season. Epidemiol Rec 2008, 83:81-88.
9. Rota P.A., Wallis T.R., Harmon M.W., Rota J.S., Kendal A.P., Nerume K. Co-circulation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990, 175:59-68.
10. Rota P.A., Hemphill M.L., Whistler T., Regnery H.L., Kendal A.P. Antigenic and genetic characterization of the haemagglutinins of recent co-circulating strains of influenza B virus. J Gen Virol 1992, 73:2737-2742.
11. McCullers J.A., Saito T., Iverson A.R. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004, 78:12817-12828.
12. Harmon M.W. Influenza viruses. Laboratory diagnosis of viral infections 1992, 515-534. Dekker, New York. 2nd ed. H. Lenette (Ed.).
13. Beyer W.E.P., Palanche A.M., Luchters C., Nauta J., Osterhaus A.D.M.E. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus Res 2004, 103:125-132.
14. European Committee for Proprietary Medicinal Products. 12 March 1997. Note for guidance on harmonization of requirements for influenza vaccines, March 1997 (CPMP/BWP/214/96). European Agency for the Evaluation of Medicinal Products, London, United Kingdom.
15. Puzelli S., Frezza F., Fabiani C., Ansaldi F., Campitelli L., Lin Y.P., et al. Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons. J Med Virol 2004, 74:629-640.
16. Kumar S., Tamura K., Nei M., MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004, 5:150-163.
17. Beyer W.E.P., Noordzij T.C., Kramer P., Diderich P.P.M.N., Op den Oek C.T., Jansen J., et al. Effect of immunomodulatory thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis. Nephron 1990, 54:296-301.
18. Keitel W.A., Cate T.R., Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccines. Am J Epidemiol 1988, 127:353-364.
19. Iorio A.M., Camilloni B., Basileo M., Neri M., Lepri E., Spighi M. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Gerontology 2007, 53:411-418.
20. Arnou R., Icardi G., De Decker M., Ambrozaitis A., Kazek M.-P., Weber F., et al. Intradermal influenza vaccination for older adults: a randomized controlled multicenter phase III study. Vaccine 2009, 27:7304-7312.
21. Levandowski R.A., Gross P.A., Weksler M., Staton E., Williams Ms., Bonelli J. Cross-reactive antibodies induced by a monovalent influenza B virus vaccine. J Clin Microbiol 1991, 29:1530-1532.
22. Zuckerman M.A., Wood J., Chakraverty P., Taylor J., Heath A.B., Oxford J.S. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J Med Virol 1991, 33:133-137.
23. Pyhala R., Kleemola M., Kumpulainen V., Vartiainen E., Lappi S., Ponka A., et al. Immune response to inactivated influenza vaccine: antibody reactivity with epidemic influenza B viruses of two distinct evolutionary lineages. Vaccine 1992, 10:631-636.
24. Barr I.G., Komandina N., Durrant C., Sjogren H., Hurt A.C., Shaw R.P. Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000. Commun Dis Intell 2006, 30:350-357.
25. Baldo V., Baldovin T., Floreani A., Fragapane E., Trivello R., the Family Medicine, et al. Response of influenza vaccine against heterovariant influenza virus strains in adults with chronic diseases. J Clin Immunol 2007, 27:542-547.
26. Camilloni B., Neri M., Lepri E., Iorio A.M. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. Vaccine 2009, 27:4099-4103.
27. Baldo V., Baldovin T., Pellegrini M., Angiolelli G., Majori S., Floreani A., et al. Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents. Clin Dev Immunol 2010, 517198. [Published online 29 March 2010]. 10.1155/2010/2010.517198.
28. Centers for Disease Control Update: influenza activity - United States and world-wide, and the composition of the 1991-1992 influenza vaccine. Morbid Mortal Wkly Rep 1991, 231:239-240.
29. Ansaldi F., D'Agaro P., Florentiis D., Puzelli S., Lin Y.P., Gregory V., et al. Molecular characterization of influenza B viruses circulating in Northern Italy during the 2001-2002 epidemic season. J Med Virol 2003, 70:463-469.
30. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine - Marshfield, Wisconsin, 2007-08 influenza season. CDC. MMWR 2008, 57:393-398.
31. Iorio A.M., Neri M., Lepri E., Camilloni B., Basileo M., Sigismondi N., et al. An influenza A/H3 outbreak during the 2004/2005 winter season in elderly vaccinated people living in a nursing home. Vaccine 2006, 24:6615-6619.
32. Evans A.S. Serologic studies of acute respiratory infection in military personnel. Yale J Biol Med 1975, 48:201-209.
33. Fox J.P., Cooney M.K., Hall C.E., Foy H.M. Influenza virus infection in Seattle families, 1975-1979, II. Pattern of injection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 1982, 6:228-242.
34. Goodeve A., Potter C.W., Clark A., Jennings R., Schild G.C., Yetts R. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection. J Hyg (Lond) 1983, 90:107-115.
35. Belshe R.B., Gruber W.C., Mendelman P.M., Metha H.B., Mahmood K., Reisinger K., et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000, 181:1133-1137.